The concept of personalised medicine is based on the premise that the effective treatment of human disease requires a patient-by-patient approach rather than the "one size fits all" strategy that has typically been employed until now. This course will explore the theory and application of personalised medicine as it relates to the drug treatment of common clinical conditions and will be delivered by leading experts in the field. 

This option is assigned to block S2-C. There are normally 3 hours of teaching on Thursdays, which may be split over more than one session. 

None.

The course will be assessed by a 2-hour examination (70%) and in-course assessment consisting of 2 components: an individual five-minute flash presentation (10%) and a take-home written assignment (20%). 

This course aims to provide students with an in-depth understanding of the scientific basis for personalised medicine and its current place and future potential in human healthcare. 

By the end of this course, students will be able to:

■ Differentiate conventional and personalised strategies for the treatment of human disease;

■ Assess the relative contribution of genomic and other biomarkers to the personalisation of drug therapy;

■ Critically appraise the current and likely future contribution of personalised medicine to the treatment of common human diseases;

■ Evaluate the challenges and opportunities afforded by personalised medicine in the context of future drug development.